A single center clinical trial to improve the treatment success rate by adjusting the color tone of submucosal injection material in Per-oral endoscopic myotomy (POEM)

Ikeda Yoshio0 个研究点目标入组 30 人开始时间: 2021年12月9日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Cases diagnosed with esophageal motility disorders (esophageal achalasia and related disorders) by high resolution manometry (HRM), esophagography, upper gastrointestinal endoscopy, etc., for which POEM is indicated. It does not matter whether previous treatment was given or not.

•1)Patients with a history of hypersensitivity to carbazochrome sodium sulfonate
•2)Cases of hereditary fructose intolerance
•3)Cases in which general anesthesia is difficult to perform
•4)Cases with infections requiring systemic treatment
•5)Pregnancy, possible pregnancy, or breastfeeding
•6)Patients with psychosis, psychiatric symptoms, or dementia for whom participation in the study is judged to be difficult
•7)Patients with respiratory diseases requiring continuous oxygen administration
•8)Patients with uncontrolled hypertension
•9) Patients with uncontrolled diabetes mellitus
•10) Other cases judged inappropriate by the investigator

发起方

Ikeda Yoshio